Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23222300.
- Also identified by DOI 10.1158/0008-5472.CAN-12-3544 and PMC identifier 3531868.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Th2 cytokines interleukin (IL)-4 and -13 are acknowledged regulators of lymphocyte proliferation and activation. They have also been well studied in the regulation of various myeloid-derived populations in tumor biology. It has become clear, however, that both cytokines can have direct effects on epithelial tumor cells expressing appropriate receptors. Changes in tumor proliferation, survival, and metastatic capability have all been ascribed to IL-4 and/or IL-13 action. Here, we evaluate the evidence to support direct tumor-promoting roles of these cytokines. We also identify the questions that should be addressed before proceeding with therapeutic approaches based on neutralization of IL-4 or IL-13 pathways.
Medical subject headings
- Cytokines
- Interleukin-13
- Interleukin-4
- Neoplasms, Glandular and Epithelial